INCB018424, a Selective Inhibitor of JAK1 and JAK2, Downregulates the Expression of Leukocyte Alkaline Phosphatase (LAP) On Circulating Granulocytes in Patients with Polycythemia Vera and Essential Thrombocythemia

被引：0
|
作者：
Passamonti, Francesco [1 ]
Rumi, Elisa [1 ]
Della Porta, Matteo G. [1 ]
Portolan, Monica [1 ]
Elena, Chiara [1 ]
Arcaini, Luca [1 ]
Pascutto, Cristiana [1 ]
Vanelli, Laura [1 ]
Vaddi, Kris [2 ]
Lazzarino, Mario [1 ]
Cazzola, Mario [1 ]
机构：
[1] Univ Pavia, Dept Hematol Oncol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
[2] Incyte Corp, Wilmington, DE USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [21] A phase 1 study of XL019 a selective JAK2 inhibitor, in patients with primary myelofibrosis and, post-polycythemia vera/essential thrombocythemia myelofibrosis
    Verstovsek, Srdan
    Pardanani, Animesh D.
    Shah, Neil P.
    Sokol, Lubomir
    Wadleigh, Martha
    Gilliland, D. Gary
    List, Alan F.
    Tefferi, Ayalew
    Kantarjian, Hagop M.
    Bui, Lynne A.
    Clary, Douglas O.
    BLOOD, 2007, 110 (11) : 170A - 170A
  • [22] Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
    Enriqueta Albizua
    Miguel Gallardo
    Santiago Barrio
    Inmaculada Rapado
    Ana Jimenez
    Rosa Ayala
    Daniel Rueda
    Beatriz Sanchez-Espiridion
    Eulalia Puigdecanet
    Blanca Espinet
    Lourdes Florensa
    Carles Besses
    Joaquin Martinez-Lopez
    Annals of Hematology, 2011, 90 : 939 - 946
  • [23] Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
    Albizua, Enriqueta
    Gallardo, Miguel
    Barrio, Santiago
    Rapado, Inmaculada
    Jimenez, Ana
    Ayala, Rosa
    Rueda, Daniel
    Sanchez-Espiridion, Beatriz
    Puigdecanet, Eulalia
    Espinet, Blanca
    Florensa, Lourdes
    Besses, Carles
    Martinez-Lopez, Joaquin
    ANNALS OF HEMATOLOGY, 2011, 90 (08) : 939 - 946
  • [24] Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)
    Verstovsek, Srdan
    Mesa, Ruben A.
    Salama, Mohamed E.
    Giles, Jennifer L. K.
    Pitou, Celine
    Zimmermann, Annamaria Hayden
    Price, Gregory L.
    Walgreen, Richard A.
    Prchal, Josef
    BLOOD, 2013, 122 (21)
  • [25] The JAK Inhibitor, INCB018424, Demonstrates Durable and Marked Clinical Responses in Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post PV/ET-MF)
    Verstovsek, Srdan
    Kantarjian, Hagop M.
    Pardanani, Animesh D.
    Thomas, Deborah
    Cortes, Jorge
    Mesa, Ruben A.
    Hogan, William J.
    Redman, John R.
    Erickson-Viitanen, Sue
    Levy, Richard
    Vaddi, Kris
    Bradley, Edward
    Fridman, Jordan
    Tefferi, Ayalew
    BLOOD, 2008, 112 (11) : 622 - 622
  • [26] JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera
    Zhang, Sujiang
    Qiu, Hongxia
    Fischer, Bruce S.
    Li, Weida
    Duan, Limin
    Sun, Xuemei
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 696 - 699
  • [27] Expression analysis of microRNA-125 in patients with polycythemia vera and essential thrombocythemia and correlation with JAK2 allele burden and laboratory findings
    Ferdowsi, S.
    Atarodi, K.
    Amirizadeh, N.
    Toogeh, G.
    Azarkeivan, A.
    Shirkoohi, R.
    Faranoush, M.
    Vaezi, M.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Naghadeh, H. Teimori
    Ghaffari, S. H.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 661 - 667
  • [28] Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation
    Hattori, Norimichi
    Fukuchi, Kunihiko
    Nakashima, Hidetoshi
    Maeda, Takashi
    Adachi, Daisuke
    Saito, Bungo
    Yanagisawa, Kouji
    Matsuda, Isao
    Nakamaki, Tsuyoshi
    Gomi, Kunihide
    Tomoyasu, Shigeru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 181 - 188
  • [29] Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation
    Norimichi Hattori
    Kunihiko Fukuchi
    Hidetoshi Nakashima
    Takashi Maeda
    Daisuke Adachi
    Bungo Saito
    Kouji Yanagisawa
    Isao Matsuda
    Tsuyoshi Nakamaki
    Kunihide Gomi
    Shigeru Tomoyasu
    International Journal of Hematology, 2008, 88 : 181 - 188
  • [30] JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
    Reis Monte-Mor, Barbara da Costa
    da Cunha, Anderson Ferreira
    Barbosa Pagnano, Katia Borgia
    Saad, Sara Terezinha
    Lorand-Metze, Irene
    Costa, Fernando Ferreira
    GENETICS AND MOLECULAR BIOLOGY, 2007, 30 (02) : 336 - 338
12345